CLEVELAND--(BUSINESS WIRE)--Athersys, Inc.
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc.
New York, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Induced Pluripotent Stem Cell (iPSC) Industry" - https://www.reportlinker.com/p05798831/?utm_source=GNW These cells are derived from somatic cells like blood or skin cells that are genetically reprogrammed into embryonic stem cell-like state for developing an unlimited source of a diverse range of human cells for therapeutic applications.
Myelodysplastic syndrome (MDS) refers to a group of bone marrow disorders that interfere with the healthy production of blood cells. Its a type of blood cancer.
DetailsCategory: DNA RNA and CellsPublished on Tuesday, 03 August 2021 10:03Hits: 636 Off-the-Shelf CAR T-cell Product Candidate Derived from Clonal Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into TRAC Locus Phase 1 Clinical Study will Evaluate Three Dosing Regimens of FT819 for Patients with Advanced B-cell Leukemias and Lymphomas SAN DIEGO, CA, USA I August 02, 2021 I Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, announced today that the first patient has been treated with FT819, an off-the-shelf chimeric antigen receptor (CAR) T-cell therapy targeting CD19+ malignancies
Cell culture is a fundamental research tool that enables scientists to probe the complexities of biology, establish drug development assays, produce recombinant proteins, and more. Choosing the most appropriate cell line to culture is often a balance between experimental need and accessibility
JHVEPhoto/Shutterstock Medexus Pharmaceuticals and medacGmbHreceiveda Complete Response Letter (CRL) from the Food and Drug Administration (FDA) for its New Drug Application (NDA) for treosulfan. The drug was being submitted for use in combination with fludarabine as a preparation for allogeneic hematopoietic stem cell transplantation (allo-HSCT). The companies had a target action date of August 11
Full TitlePhase 1 Study of Escalating Single and Multiple Doses of Mana 312 (Multi Tumor-Associated Antigen T cells) Administered to Adult Subjects with Acute Myeloid Leukemia or Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell TransplantPurpose The purpose of this study is to find the best dose of an investigational treatment called Mana 312 that can be given in patients who receive a donated (allogeneic) stem cell transplant as treatment for acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors.
When someone uses the term adult stem cells you might think that simply means stem cells from adults. However, its not that simple.
Latest released the research study on Global Stem Cell Antibody Market, offers a detailed overview of the factors influencing the global business scope. Stem Cell Antibody Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services.
Recent Comments